A U.S. district court allowed a false advertising case under the Lanham Act to continue even though the defendant’s product is not yet being sold. CareDx Inc. sued Natera Inc. over advertising claims it made for its kidney transplant rejection test Prospera before the test was on the market. CareDx alleged Natera made statements comparing its Prospera study results with study... Read More